SG11202009314XA - Heterocyclic compound - Google Patents

Heterocyclic compound

Info

Publication number
SG11202009314XA
SG11202009314XA SG11202009314XA SG11202009314XA SG11202009314XA SG 11202009314X A SG11202009314X A SG 11202009314XA SG 11202009314X A SG11202009314X A SG 11202009314XA SG 11202009314X A SG11202009314X A SG 11202009314XA SG 11202009314X A SG11202009314X A SG 11202009314XA
Authority
SG
Singapore
Prior art keywords
heterocyclic compound
heterocyclic
compound
Prior art date
Application number
SG11202009314XA
Other languages
English (en)
Inventor
Yoshinori Yoshida
Kenji Miki
Akira Kaieda
Shigeru Kondo
Hiroshi Nara
Yoshinori Ikeura
Original Assignee
Univ Kyoto
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Kyoto, Takeda Pharmaceuticals Co filed Critical Univ Kyoto
Publication of SG11202009314XA publication Critical patent/SG11202009314XA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0652Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0657Cardiomyocytes; Heart cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40Regulators of development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999Small molecules not provided for elsewhere

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Cell Biology (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
SG11202009314XA 2018-03-30 2019-03-28 Heterocyclic compound SG11202009314XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018069872 2018-03-30
PCT/JP2019/013529 WO2019189553A1 (ja) 2018-03-30 2019-03-28 複素環化合物

Publications (1)

Publication Number Publication Date
SG11202009314XA true SG11202009314XA (en) 2020-10-29

Family

ID=68059192

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202009314XA SG11202009314XA (en) 2018-03-30 2019-03-28 Heterocyclic compound

Country Status (15)

Country Link
US (1) US11401264B2 (zh)
EP (1) EP3778587B1 (zh)
JP (1) JP7257698B2 (zh)
KR (1) KR20200139210A (zh)
CN (1) CN111918866B (zh)
AU (1) AU2019241702B2 (zh)
BR (1) BR112020019579A8 (zh)
CA (1) CA3095717A1 (zh)
CO (1) CO2020012101A2 (zh)
ES (1) ES2966207T3 (zh)
IL (1) IL277340B2 (zh)
MX (1) MX2020010184A (zh)
SG (1) SG11202009314XA (zh)
TW (1) TWI820104B (zh)
WO (1) WO2019189553A1 (zh)

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614519A (en) 1991-02-06 1997-03-25 Karl Thomae Gmbh (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists
US5594003A (en) 1991-02-06 1997-01-14 Dr. Karl Thomae Gmbh Tetrahydroimidazo[1,2-a]pyridin-2-yl-(benzimidazol-1-yl)-methyl-biphenyls useful as angiotensin-II antagonists
US5602127A (en) 1991-02-06 1997-02-11 Karl Thomae Gmbh (Alkanesultam-1-yl)-benzimidazol-1-yl)-1yl)-methyl-biphenyls useful as angiotensin-II antagonists
SI9210098B (sl) * 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
DE4212748A1 (de) 1992-04-16 1993-10-21 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
KR101164104B1 (ko) 2003-10-03 2012-07-12 게이이치 후쿠다 줄기세포로부터 심근세포의 분화를 유도하는 방법
RU2006139594A (ru) 2004-04-10 2008-05-20 Хенкель Коммандитгезелльшафт Ауф Акциен (DE) Устройство для завивки волос
CN101228264B (zh) 2005-06-22 2017-12-26 阿斯特利亚斯生物治疗股份公司 使灵长类多能干细胞分化成心肌细胞系细胞
EA014166B1 (ru) 2005-12-13 2010-10-29 Киото Юниверсити Ядерный фактор перепрограммирования
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
CA2650685C (en) 2006-04-28 2014-02-04 Asubio Pharma Co., Ltd. Method for inducing differentiation of pluripotent stem cells into cardiomyocytes
US7661738B2 (en) 2006-11-28 2010-02-16 Veritainer Corporation Radiation detection unit for mounting a radiation sensor to a container crane
US9382515B2 (en) 2007-04-07 2016-07-05 Whitehead Institute For Biomedical Research Reprogramming of somatic cells
WO2008151058A2 (en) 2007-05-30 2008-12-11 The General Hospital Corporation Methods of generating pluripotent cells from somatic cells
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
US8765465B2 (en) 2008-03-26 2014-07-01 Kyoto University Efficient production and use of highly cardiogenic progenitors and cardiomyocytes from embryonic and induced pluripotent stem cells
US9499790B2 (en) 2010-08-26 2016-11-22 Kyoto University Method for promoting differentiation of pluripotent stem cells into cardiac muscle cells
CN103209968B (zh) * 2010-08-26 2015-08-05 国立大学法人京都大学 多能干细胞心肌细胞分化促进剂
JP5840855B2 (ja) 2011-03-30 2016-01-06 学校法人東京女子医科大学 胚性幹細胞から心筋シートを製造する方法
US9764063B2 (en) 2012-03-15 2017-09-19 Iheart Japan Corporation Method for producing mixed cell population of cardiomyocytes and vascular cells from induced pluripotent stem cell
WO2014192909A1 (ja) 2013-05-31 2014-12-04 iHeart Japan株式会社 ハイドロゲルを組み込んだ積層化細胞シート
HUE049916T2 (hu) * 2013-06-11 2020-11-30 Ncardia B V Tenyésztõközeg-készítmények pluripotens emlõs õssejtekbõl származó szívizomsejtek érlelésére
WO2015182765A1 (ja) * 2014-05-30 2015-12-03 国立大学法人京都大学 低分子化合物を用いた多能性幹細胞の心筋分化誘導法
EP3219790B1 (en) 2014-11-12 2021-08-04 Terumo Kabushiki Kaisha Myocardial cell sheet
JP2017060422A (ja) * 2015-09-24 2017-03-30 国立大学法人 東京大学 成熟した心筋細胞を分化誘導させる方法
JP6702134B2 (ja) 2016-10-27 2020-05-27 トヨタ自動車株式会社 電動車両

Also Published As

Publication number Publication date
EP3778587A1 (en) 2021-02-17
RU2020135574A (ru) 2022-05-04
MX2020010184A (es) 2020-10-28
US11401264B2 (en) 2022-08-02
EP3778587B1 (en) 2023-10-04
AU2019241702A1 (en) 2020-10-08
CA3095717A1 (en) 2019-10-03
CN111918866A (zh) 2020-11-10
CO2020012101A2 (es) 2020-12-10
KR20200139210A (ko) 2020-12-11
US20210024512A1 (en) 2021-01-28
IL277340A (en) 2020-10-29
WO2019189553A1 (ja) 2019-10-03
JP7257698B2 (ja) 2023-04-14
EP3778587A4 (en) 2021-10-06
AU2019241702B2 (en) 2023-07-27
CN111918866B (zh) 2023-07-04
JPWO2019189553A1 (ja) 2021-03-25
TW201942354A (zh) 2019-11-01
BR112020019579A8 (pt) 2022-10-18
TWI820104B (zh) 2023-11-01
BR112020019579A2 (pt) 2021-01-12
IL277340B2 (en) 2024-07-01
IL277340B1 (en) 2024-03-01
EP3778587C0 (en) 2023-10-04
ES2966207T3 (es) 2024-04-18

Similar Documents

Publication Publication Date Title
ZA201807249B (en) Heterocyclic compound
IL283333A (en) Heterocyclic compounds
IL280821A (en) Heterocycline compound
EP3600327A4 (en) HETEROCYCLIC COMPOUND
EP3689879A4 (en) HETEROCYCLIC CONNECTION
EP3896060A4 (en) HETEROCYCLIC COMPOUND
EP3895707A4 (en) HETEROCYCLIC COMPOUND
ZA202104402B (en) Heterocyclic compound
IL289617A (en) Heterocyclic compounds
IL289595A (en) Heterocyclic compounds
PT3643718T (pt) Composto heterocíclico e seu uso como modulador alostérico positivo do recetor muscarínico colinérgico m1
EP3578549A4 (en) HETEROCYCLIC CONNECTION
IL288987A (en) New heterocyclic compounds
EP3660003C0 (en) HETEROCYCLIC COMPOUND
EP3693368C0 (en) HETEROCYCLIC COMPOUND
EP3747885A4 (en) HETEROCYCLIC CONNECTION
EP3693360C0 (en) HETEROCYCLIC COMPOUNDS
SG11202009356RA (en) Heterocyclic compound
EP3831811A4 (en) HETEROCYCLIC COMPOUND
ZA201907792B (en) Heterocyclic compound
AU2018289939A1 (en) Heterocyclic compound
IL277340A (en) The orthocyclic compound
ZA201907793B (en) Heterocyclic compound
GB201808580D0 (en) Heterocyclic compounds
GB201806488D0 (en) Heterocyclic TADF compounds